Last $0.64 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:10 PM 02/26/15 All times are local (Market data is delayed by at least 15 minutes).

tikcro technologies ltd (TIKRF) Snapshot

Open
$0.64
Previous Close
$0.64
Day High
$0.64
Day Low
$0.64
52 Week High
02/12/15 - $0.65
52 Week Low
12/29/14 - $0.46
Market Cap
5.7M
Average Volume 10 Days
937.0
EPS TTM
$-0.09
Shares Outstanding
8.9M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for TIKCRO TECHNOLOGIES LTD (TIKRF)

Related News

No related news articles were found.

tikcro technologies ltd (TIKRF) Related Businessweek News

No Related Businessweek News Found

tikcro technologies ltd (TIKRF) Details

Tikcro Technologies Ltd. does not have significant operations. It focuses to provide funding for early-stage biotechnology projects. Previously, the company was engaged in the discovery, development, and commercialization of novel therapies for treating solid cancer tumors. Tikcro Technologies Ltd. was founded in 1999 and is based in Raanana, Israel.

1 Employees
Last Reported Date: 04/30/14
Founded in 1999

tikcro technologies ltd (TIKRF) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

tikcro technologies ltd (TIKRF) Key Developments

Tikcro Technologies Ltd. Signs Research and License Agreement Regarding Cancer Immune Checkpoint Antibodies

Tikcro Technologies Ltd. announced that it has entered into a research and license agreement with Yeda Research and Development Company Ltd., the technology transfer arm of the Weizmann Institute of Science in Israel. This agreement is for the development of new antibodies originating from specified research at the Weizmann Institute of Science addressing identified targets of cancer immune checkpoints. Under the agreement, Tikcro will provide funding for further research at the Weizmann Institute of Science to develop certain antibodies selected and verified in pre-clinical trials. The antibodies may have high selectivity and binding qualities towards cancer immune checkpoints. Further research and development will be required to promote such antibodies as therapeutic candidates for immune modulation in oncology. Tikcro, alone or through sub-licensees, will have the right to obtain the research results and to pursue development through commercialization. The license consideration due from Tikcro to Yeda includes royalties from net sales, sub-license fees and fixed fees linked to clinical and commercial sales milestones.

Tikcro Technologies Ltd., Annual General Meeting, Dec 29, 2014

Tikcro Technologies Ltd., Annual General Meeting, Dec 29, 2014., at 12:00 Israel Standard Time. Location: The law offices of Goldfarb Seligman & Co., Electra Tower. Agenda: To consider re-election of Eric Paneth and Izhak Tamir to the Board of Directors; to consider re-appointment of Kost Forer Gabbay and Kasierer, a member of Ernst & Young Global, as independent auditors; and to consider audited financial statements for the year ended December 31, 2013.

Tikcro Technologies Ltd. Announces Unaudited Earnings Results for the Third Quarter and Nine Months September 30, 2014

Tikcro Technologies Ltd. announced unaudited earnings results for the third quarter and nine months September 30, 2014. Net loss for the third quarter was $254,000, or $0.03 per diluted share against net profit of $386,000 or $0.04 per diluted share a year ago. Excluding this non-cash financial expense, net loss for the third quarter was $132,000 or $0.01 per diluted share. Operating loss was $132,000 against $204,000 a year ago. For the nine months, operating loss was $319,000 against $448,000 a year ago. Net loss was $388,000 or $0.04 per diluted share against net income of $444,000 or $0.05 per diluted share a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TIKRF:US $0.64 USD 0.00

TIKRF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TIKRF.
View Industry Companies
 

Industry Analysis

TIKRF

Industry Average

Valuation TIKRF Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 0.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TIKCRO TECHNOLOGIES LTD, please visit www.tikcro.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.